tat Gene Products, Human Immunodeficiency Virus
"tat Gene Products, Human Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS.
| Descriptor ID |
D054322
|
| MeSH Number(s) |
D12.776.260.755.199.500 D12.776.930.900.199.500 D12.776.964.775.562.773 D12.776.964.925.984.400.500
|
| Concept/Terms |
tat Gene Products, Human Immunodeficiency Virus- tat Gene Products, Human Immunodeficiency Virus
- Trans-Acting Transcription Factor, HIV
- Trans Acting Transcription Factor, HIV
- HIV tat Protein
- tat Protein, HIV
- HIV Transacting Transcription Protein
|
Below are MeSH descriptors whose meaning is more general than "tat Gene Products, Human Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "tat Gene Products, Human Immunodeficiency Virus".
This graph shows the total number of publications written about "tat Gene Products, Human Immunodeficiency Virus" by people in this website by year, and whether "tat Gene Products, Human Immunodeficiency Virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "tat Gene Products, Human Immunodeficiency Virus" by people in Profiles.
-
Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport. J Neuroimmune Pharmacol. 2021 12; 16(4):854-869.
-
Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia Activation. J Neuroimmune Pharmacol. 2020 06; 15(2):209-223.
-
Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport. Sci Rep. 2019 03 07; 9(1):3843.
-
HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription. Retrovirology. 2018 05 23; 15(1):39.
-
Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. Sci Rep. 2017 06 16; 7(1):3694.
-
Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport. Sci Rep. 2016 12 14; 6:39048.
-
HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. J Neurovirol. 2016 06; 22(3):282-92.
-
Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport. J Neuroimmune Pharmacol. 2015 Mar; 10(1):122-35.
-
Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates. Bioorg Med Chem Lett. 2013 Oct 15; 23(20):5689-93.
-
Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide. Biomaterials. 2010 Feb; 31(4):769-78.